Cidara Thera (CDTX)

$52.26 +0.76 (1.49%)
Market Cap 1.04B
Revenue (ttm) 1.28M
Net Income (ttm) -169.83M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -13,267.97%
Debt to Equity Ratio 0.00
Volume 437,100
Avg Vol 717,638
Day's Range N/A - N/A
Shares Out 20.16M
Stochastic %K 66%
Beta 1.14
Analysts Strong Sell
Price Target $59.17

Company Profile

Cidara Therapeutics, Inc. operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases. The company's product includes rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also develops its Cloudbreak platform that enab...

Industry: Biotechnology
Sector: Healthcare
Phone: (858) 752-6170
Address:
6310 Nancy Ridge Drive, Suite 101, San Diego, United States
mattsprat
mattsprat Jul. 16 at 8:18 PM
$CDTX power hour never disappoints! Can buy almost every day the first 2 hours at a discount (yes, currently CHEAP). I’m not short playing but the daily chart & pattern looks like fun day trades.
0 · Reply
rickahuna
rickahuna Jul. 16 at 5:50 PM
$CDTX @@@ $51.51 $0.01 (0.02%)
0 · Reply
Diefreeandsell
Diefreeandsell Jul. 16 at 1:04 AM
$CDTX Breakout? Breakdown? Friday?
1 · Reply
Unterhund70
Unterhund70 Jul. 15 at 5:18 PM
$CDTX well, maybe not! Red day generally, it seems.
0 · Reply
CaliEmpress
CaliEmpress Jul. 15 at 4:18 PM
$CDTX Low point of the day and we run from here.
1 · Reply
Bvega415
Bvega415 Jul. 15 at 2:17 PM
$CDTX added 150 shrs @ $53
0 · Reply
Unterhund70
Unterhund70 Jul. 15 at 1:45 PM
$CDTX Usual morning nonsense!
0 · Reply
_nic
_nic Jul. 15 at 1:39 PM
$CDTX daily Round Trip?
0 · Reply
veryboredXYZ
veryboredXYZ Jul. 15 at 11:05 AM
$CDTX wouldn't be surprised to see this trying to settle at 60 this and upcoming week.
0 · Reply
watchaddict
watchaddict Jul. 14 at 8:23 PM
$CDTX Woah seconds after the close a 521,600 share buy @55.23
2 · Reply
Latest News on CDTX
Segal Trials Contributes to Breakthrough Flu Prevention Study Led by Cidara Therapeutics

Jul 7, 2025, 1:00 PM EDT - 9 days ago

Segal Trials Contributes to Breakthrough Flu Prevention Study Led by Cidara Therapeutics

Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Jul 1, 2025, 4:59 PM EDT - 15 days ago

Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Cidara Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes

Jun 30, 2025, 8:00 AM EDT - 16 days ago

Cidara Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes

Cidara Announces Closing of Upsized Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Jun 26, 2025, 5:15 PM EDT - 20 days ago

Cidara Announces Closing of Upsized Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Cidara Therapeutics Advances CD388 To Phase 3, Reiterate Buy

Jun 25, 2025, 7:30 AM EDT - 21 days ago

Cidara Therapeutics Advances CD388 To Phase 3, Reiterate Buy

Cidara Announces Pricing of Upsized Public Offering of Common Stock

Jun 24, 2025, 8:00 PM EDT - 22 days ago

Cidara Announces Pricing of Upsized Public Offering of Common Stock

Cidara Announces Proposed Public Offering of Common Stock

Jun 23, 2025, 4:15 PM EDT - 23 days ago

Cidara Announces Proposed Public Offering of Common Stock

Why Is Cidara Therapeutics Stock Trading Higher On Monday?

Jun 23, 2025, 11:00 AM EDT - 23 days ago

Why Is Cidara Therapeutics Stock Trading Higher On Monday?

Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza

Jun 23, 2025, 7:00 AM EDT - 23 days ago

Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza

Cidara Therapeutics: All Stars Aligning In Favor Of CD388

May 25, 2025, 9:26 PM EDT - 7 weeks ago

Cidara Therapeutics: All Stars Aligning In Favor Of CD388

Cidara Therapeutics to Host Virtual R&D Day to Discuss CD388 as a Potential Universal, Once-Per-Flu Season Preventative of Seasonal and Pandemic Influenza on May 22, 2025

May 15, 2025, 8:00 AM EDT - 2 months ago

Cidara Therapeutics to Host Virtual R&D Day to Discuss CD388 as a Potential Universal, Once-Per-Flu Season Preventative of Seasonal and Pandemic Influenza on May 22, 2025

Cidara Therapeutics to Participate in Two Upcoming Investor Conferences

May 13, 2025, 8:00 AM EDT - 2 months ago

Cidara Therapeutics to Participate in Two Upcoming Investor Conferences

Cidara Therapeutics, Inc. (CDTX) Q1 2025 Earnings Call Transcript

May 10, 2025, 9:29 PM EDT - 2 months ago

Cidara Therapeutics, Inc. (CDTX) Q1 2025 Earnings Call Transcript

Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results

May 8, 2025, 4:15 PM EDT - 2 months ago

Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results

Cidara Therapeutics: Strong Buy On Imminent Data Readout For Lead Flu Candidate

May 5, 2025, 5:00 AM EDT - 2 months ago

Cidara Therapeutics: Strong Buy On Imminent Data Readout For Lead Flu Candidate

Cidara Therapeutics Announces Promotion of Nicole Davarpanah to Chief Medical Officer and Corrina Pavetto to SVP, Clinical Development

May 1, 2025, 8:00 AM EDT - 2 months ago

Cidara Therapeutics Announces Promotion of Nicole Davarpanah to Chief Medical Officer and Corrina Pavetto to SVP, Clinical Development

Cidara Therapeutics to Participate in The Citizens Life Sciences Conference

Apr 30, 2025, 8:00 AM EDT - 2 months ago

Cidara Therapeutics to Participate in The Citizens Life Sciences Conference

Cidara Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 8, 2025

Apr 24, 2025, 8:00 AM EDT - 2 months ago

Cidara Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 8, 2025

Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors

Apr 16, 2025, 8:00 AM EDT - 3 months ago

Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors

PHAT

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Apr 1, 2025, 4:56 PM EDT - 3 months ago

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Cidara Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 4:05 PM EDT - 3 months ago

Cidara Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

Cidara Therapeutics to Participate in World Health Organization Meeting on H5N1 Influenza Preparedness and Response

Mar 19, 2025, 8:00 AM EDT - 4 months ago

Cidara Therapeutics to Participate in World Health Organization Meeting on H5N1 Influenza Preparedness and Response

Cidara Therapeutics Announces Two Presentations on CD388 in Influenza at International Conference on Antiviral Research (ICAR) 2025

Mar 18, 2025, 8:00 AM EDT - 4 months ago

Cidara Therapeutics Announces Two Presentations on CD388 in Influenza at International Conference on Antiviral Research (ICAR) 2025

Cidara Therapeutics Announces Publication of CD388 Preclinical Data in Nature Microbiology

Mar 17, 2025, 6:00 AM EDT - 4 months ago

Cidara Therapeutics Announces Publication of CD388 Preclinical Data in Nature Microbiology

Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 6, 2025, 4:35 PM EST - 4 months ago

Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Cidara Therapeutics Announces Appointment of Frank Karbe as Chief Financial Officer

Feb 18, 2025, 4:15 PM EST - 5 months ago

Cidara Therapeutics Announces Appointment of Frank Karbe as Chief Financial Officer

Bullish On Cidara Therapeutics As It Doubles Down On CD388 For Universal Flu Prevention

Feb 11, 2025, 8:22 AM EST - 5 months ago

Bullish On Cidara Therapeutics As It Doubles Down On CD388 For Universal Flu Prevention

Cidara Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Jan 30, 2025, 4:05 PM EST - 5 months ago

Cidara Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Cidara: Potential To Change Flu Prophylaxis Landscape With CD388

Nov 21, 2024, 3:12 PM EST - 8 months ago

Cidara: Potential To Change Flu Prophylaxis Landscape With CD388

Cidara Therapeutics Announces $105 Million Private Placement

Nov 21, 2024, 8:30 AM EST - 8 months ago

Cidara Therapeutics Announces $105 Million Private Placement

Cidara Therapeutics to Participate in Evercore 7th Annual HealthCONx Conference

Nov 19, 2024, 8:00 AM EST - 8 months ago

Cidara Therapeutics to Participate in Evercore 7th Annual HealthCONx Conference

Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Nov 7, 2024, 4:15 PM EST - 8 months ago

Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Cidara Therapeutics to Participate in Two Upcoming November Investor Conferences

Oct 31, 2024, 8:00 AM EDT - 9 months ago

Cidara Therapeutics to Participate in Two Upcoming November Investor Conferences

Cidara Therapeutics Announces Two Presentations on Innovative Drug-Fc Conjugate, CD388, at the 2024 OPTIONS XII for the Control of Influenza Conference

Sep 25, 2024, 8:00 AM EDT - 10 months ago

Cidara Therapeutics Announces Two Presentations on Innovative Drug-Fc Conjugate, CD388, at the 2024 OPTIONS XII for the Control of Influenza Conference

Cidara Therapeutics Announces First Subjects Dosed in Phase 2b NAVIGATE Trial Evaluating CD388 for the Prevention of Seasonal Influenza

Sep 23, 2024, 8:00 AM EDT - 10 months ago

Cidara Therapeutics Announces First Subjects Dosed in Phase 2b NAVIGATE Trial Evaluating CD388 for the Prevention of Seasonal Influenza

Cidara Therapeutics Strengthens its Scientific Advisory Board with Infectious Disease Experts

Sep 19, 2024, 8:00 AM EDT - 10 months ago

Cidara Therapeutics Strengthens its Scientific Advisory Board with Infectious Disease Experts

Cidara Therapeutics Restructures Workforce to Focus on Planned Clinical Development of CD388

Sep 12, 2024, 4:05 PM EDT - 10 months ago

Cidara Therapeutics Restructures Workforce to Focus on Planned Clinical Development of CD388

Cidara to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 5, 2024, 8:00 AM EDT - 11 months ago

Cidara to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Cidara Therapeutics Announces Appointment of Jim Beitel as Chief Business Officer

Aug 19, 2024, 5:12 PM EDT - 11 months ago

Cidara Therapeutics Announces Appointment of Jim Beitel as Chief Business Officer

Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results

Aug 13, 2024, 4:29 PM EDT - 1 year ago

Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Jul 3, 2024, 1:05 PM EDT - 1 year ago

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Cidara Therapeutics to Present Preclinical Data on CD388 at ASM Microbe 2024 Conference

May 30, 2024, 8:00 AM EDT - 1 year ago

Cidara Therapeutics to Present Preclinical Data on CD388 at ASM Microbe 2024 Conference

Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

May 15, 2024, 4:20 PM EDT - 1 year ago

Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

Cidara Therapeutics Regains Compliance with Nasdaq Continued Listing Rules

May 15, 2024, 4:01 PM EDT - 1 year ago

Cidara Therapeutics Regains Compliance with Nasdaq Continued Listing Rules

Cidara Therapeutics: Now Well-Funded To Advance Its Cloudbreak Platform

Apr 26, 2024, 6:01 PM EDT - 1 year ago

Cidara Therapeutics: Now Well-Funded To Advance Its Cloudbreak Platform

Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388 at ESCMID 2024

Apr 26, 2024, 8:00 AM EDT - 1 year ago

Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388 at ESCMID 2024

Cidara Therapeutics shares surge 30% after reacquiring flu treatment

Apr 24, 2024, 7:19 PM EDT - 1 year ago

Cidara Therapeutics shares surge 30% after reacquiring flu treatment

Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million

Apr 24, 2024, 4:05 PM EDT - 1 year ago

Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million

Cidara Therapeutics Announces Divestiture of Rezafungin to Mundipharma* to Focus on Advancing the Clinical Development of Cloudbreak DFC Pipeline

Apr 24, 2024, 4:01 PM EDT - 1 year ago

Cidara Therapeutics Announces Divestiture of Rezafungin to Mundipharma* to Focus on Advancing the Clinical Development of Cloudbreak DFC Pipeline

Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Apr 22, 2024, 5:10 PM EDT - 1 year ago

Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

mattsprat
mattsprat Jul. 16 at 8:18 PM
$CDTX power hour never disappoints! Can buy almost every day the first 2 hours at a discount (yes, currently CHEAP). I’m not short playing but the daily chart & pattern looks like fun day trades.
0 · Reply
rickahuna
rickahuna Jul. 16 at 5:50 PM
$CDTX @@@ $51.51 $0.01 (0.02%)
0 · Reply
Diefreeandsell
Diefreeandsell Jul. 16 at 1:04 AM
$CDTX Breakout? Breakdown? Friday?
1 · Reply
Unterhund70
Unterhund70 Jul. 15 at 5:18 PM
$CDTX well, maybe not! Red day generally, it seems.
0 · Reply
CaliEmpress
CaliEmpress Jul. 15 at 4:18 PM
$CDTX Low point of the day and we run from here.
1 · Reply
Bvega415
Bvega415 Jul. 15 at 2:17 PM
$CDTX added 150 shrs @ $53
0 · Reply
Unterhund70
Unterhund70 Jul. 15 at 1:45 PM
$CDTX Usual morning nonsense!
0 · Reply
_nic
_nic Jul. 15 at 1:39 PM
$CDTX daily Round Trip?
0 · Reply
veryboredXYZ
veryboredXYZ Jul. 15 at 11:05 AM
$CDTX wouldn't be surprised to see this trying to settle at 60 this and upcoming week.
0 · Reply
watchaddict
watchaddict Jul. 14 at 8:23 PM
$CDTX Woah seconds after the close a 521,600 share buy @55.23
2 · Reply
RonIsWrong
RonIsWrong Jul. 14 at 7:24 PM
$CDTX 👀
2 · Reply
form4ai
form4ai Jul. 14 at 7:00 PM
$CDTX get insider alert on directly to your phone just seconds after it got filed!
0 · Reply
CaliEmpress
CaliEmpress Jul. 14 at 6:54 PM
$CDTX I don’t know if it’s sad or funny that I make a day what I used to make in 2 years working 12 hours a day, 5 days a week. Maybe all these hard years prepared me for these investing opportunities and decisions.
2 · Reply
watchaddict
watchaddict Jul. 14 at 6:33 PM
$CDTX 56+ close
0 · Reply
mattsprat
mattsprat Jul. 14 at 6:04 PM
$CDTX .05 spread♥️♥️♥️
0 · Reply
Nebler
Nebler Jul. 14 at 5:46 PM
$CDTX longs are getting rewarded heavy here!!
0 · Reply
CaliEmpress
CaliEmpress Jul. 14 at 5:40 PM
$CDTX If this is not news leak then I don’t know what is.
1 · Reply
mattsprat
mattsprat Jul. 14 at 5:34 PM
$CDTX short walk to $300
0 · Reply
Unterhund70
Unterhund70 Jul. 14 at 5:20 PM
$CDTX short squeeze? Partnership news pending? A little bit of both?
1 · Reply
veryboredXYZ
veryboredXYZ Jul. 14 at 4:16 PM
$CDTX
0 · Reply
Unterhund70
Unterhund70 Jul. 14 at 4:07 PM
$CDTX Even with the recent offering, the actual free float is likely quite tiny compared to overall shares outstanding. A big slice of the company is owned by institutional investors, some of whom have been doubling down (not selling). There is is also a big chunk in preferreds and RSUs. Then we have the stampede of short sellors selling the few available shares they could find hoping to fade the phase 2b/offering news... Makes for a pretty volatile setup! I'm happy to be long and long-term!
0 · Reply
CaliEmpress
CaliEmpress Jul. 14 at 3:17 PM
$CDTX 🫶
0 · Reply